Skip to content
Recall Observatory FDA recall evidence

Drug product

Propofol Injectable Emulsion, 1%, (10mg/mL), packaged in a) 200 mg/20 mL, 5 Units x 20 mL Single patient infusion vials per carton (NDC 0409-4699-30); b) 1 g/100 mL, 10 Units x 100 mL Single patient infusion vials per carton (NDC 0409-4699-24); Rx only, Hospira, Inc., Lake Forest, IL 60045, USA.

D-1382-2012

April 11, 2012

Class II

Product summary

Firm
Hospira, Inc.
Event
Event 62009
Status
Terminated
Classification
Class II
Quantity
a) 36,125 vials; b) 31,280 vials
Official record key
drug-enforcement:D-1382-2012

Official wording

Reason: Presence of Particulate Matter: A single visible particulate was observed in a retention sample bottles identified as stainless steel

Code information: Lot #: a) 03440DJ*, Exp 1MAR2013; b) 07947DJ, Exp 1JUL2013; 10134DJ, Exp 1OCT2013; Note: * the lot may be followed by 01.

Distribution pattern: Nationwide.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Particulate Matter